Elsevier

Maturitas

Volume 1, Issue 4, June 1979, Pages 247-259
Maturitas

Review
Hormone therapy and affect

https://doi.org/10.1016/0378-5122(79)90015-XGet rights and content

Abstract

This study investigated the influence of hormone therapy on affect in a double blind crossover trial. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethinyl oestradiol — 50 μg/day, levonorgestrel — 250 μg/day, “Nordial” — a combination of these two substances, and placebo. Affect was measured by the Hamilton Depression Rating Scale, verbal reports by women and self-ratings on visual analogue scales. Ethinyl oestradiol was found to have a beneficial influence on aspects of affect such as Hamilton scores, anxiety, irritability and insomnia.

The influence of hormones on Hamilton scores could be partly but not fully explained by the alleviation of hot flushes. Norgestrel showed less favourable changes initially but these tended to diminish by the third therapy month. Most of the women studied were not clinically depressed. Anxiety symptoms were the major features exhibited in the group of women investigated. The results of this study suggest that visual analogue rating scales are of questionable validity in assessing affect in patients without any appreciable psychiatric morbidity.

References (17)

  • L. Dennerstein et al.

    A review of studies of the psychological symptoms found at the menopause

    Maturitas

    (1978)
  • G.L. Klerman

    Anxiety and depression

  • S. Campbell

    Double blind psychometric studies on the effects of natural estrogens on post-menopausal women

  • J. Coope

    Double blind crossover study of estrogen replacement therapy

  • M. Aylward

    Estrogens, plasma tryptophan levels in perimenopausal patients

  • P. Fedor-Freybergh

    The influence of oestrogens on the well-being and mental performance in climacteric and postmenopausal women

    Acta Obstet. Gynecol. Scand.

    (1977)
  • R.D. Gambrell

    Estrogens, progestagens and endometrial cancer

  • J.L. Bullock et al.

    Use of medroxyprogesterone acetate to prevent menopausal symptoms

    Obstet. Gynecol.

    (1975)
There are more references available in the full text version of this article.

Cited by (0)

View full text